The RADAR-Canada trial is a pilot RCT undertaken to assess the acceptability of, compliance with, and biologic consequences of a deresuscitation protocol designed to expedite the removal of excess interstitial fluid in patients who remain in a positive fluid balance following admission to an intensive care unit (ICU).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Efficacy: Mean cumulative fluid balance
Timeframe: 72 hours following randomization
Compliance with deresuscitation protocol
Timeframe: Each 24 hours over first week
Acceptability of protocol
Timeframe: Day 1